Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
DEL PRIS
SecurityDE:ABL / Abbott Laboratories
InstitutionAlly Financial Inc.
Latest Disclosed Ownership64,000 shares
Latest Disclosed Value $ 6,570,880
Ally Financial Inc. reports 166.67% increase in ownership of ABL / Abbott Laboratories

On May 12, 2026 - Ally Financial Inc. filed a 13F-HR form disclosing ownership of 64,000 shares of Abbott Laboratories (DE:ABL) valued at $5,684,480 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 24,000 shares of Abbott Laboratories. This represents a change in shares of 166.67% during the quarter. The current value of the position is $4,814,080 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Abbott Laboratories COM 002824100 64,000 40,000 166.67 6,571 118.56 0.8175
2026-02-13 2025-12-31 13F Abbott Laboratories COM 002824100 24,000 8,000 50.00 3,007 40.27 0.3672
2025-11-13 2025-09-30 13F Abbott Laboratories COM 002824100 16,000 16,000 2,143 0.2646
2025-05-14 2025-03-31 13F Abbott Laboratories COM 002824100 0 -34,000 -100.00 0 -100.00
2025-02-13 2024-12-31 13F Abbott Laboratories COM 002824100 34,000 0 0.00 3,846 -0.80 0.4690
2024-11-13 2024-09-30 13F Abbott Laboratories COM 002824100 34,000 0 0.00 3,876 9.74 0.4682
2024-08-13 2024-06-30 13F Abbott Laboratories COM 002824100 34,000 25,000 277.78 3,533 245.60 0.4382
2024-05-14 2024-03-31 13F Abbott Laboratories COM 002824100 9,000 -22,000 -70.97 1,023 -70.05 0.1381
2024-02-13 2023-12-31 13F Abbott Laboratories COM 002824100 31,000 0 0.00 3,412 13.66 0.4459
2023-11-13 2023-09-30 13F Abbott Laboratories COM 002824100 31,000 12,000 63.16 3,002 44.95 0.4414
2023-08-11 2023-06-30 13F Abbott Laboratories COM 002824100 19,000 10,000 111.11 2,071 127.33 0.2898
2023-05-12 2023-03-31 13F Abbott Laboratories COM 002824100 9,000 0 0.00 911 -7.79 0.1349
2023-02-13 2022-12-31 13F Abbott Laboratories COM 002824100 9,000 0 0.00 988 13.43 0.1540
2022-11-10 2022-09-30 13F Abbott Laboratories COM 002824100 9,000 0 0.00 871 -10.94 0.1437
2022-08-10 2022-06-30 13F Abbott Laboratories COM 002824100 9,000 0 0.00 978 -8.17 0.1334
2022-05-13 2022-03-31 13F Abbott Laboratories COM 002824100 9,000 9,000 1,065 0.1227
2018-11-13 2018-09-30 13F Abbott Laboratories COM 002824100 0 -25,000 -100.00 0 -100.00
2018-08-13 2018-06-30 13F Abbott Laboratories COM 002824100 25,000 0 0.00 1,525 1.80 0.2996
2018-05-14 2018-03-31 13F Abbott Laboratories COM 002824100 25,000 25,000 1,498 0.2244
2017-11-13 2017-09-30 13F Abbott Laboratories COM 002824100 0 -65,000 -100.00 0 -100.00
2017-08-11 2017-06-30 13F Abbott Laboratories COM 002824100 65,000 0 0.00 3,160 9.46 0.6263
2017-05-12 2017-03-31 13F Abbott Laboratories COM 002824100 65,000 0 0.00 2,887 15.62 0.6509
2017-02-13 2016-12-31 13F Abbott Laboratories COM 002824100 65,000 0 0.00 2,497 -9.17 0.4195
2016-11-14 2016-09-30 13F Abbott Laboratories COM 002824100 65,000 0 0.00 2,749 7.59 0.4824
2016-08-12 2016-06-30 13F Abbott Laboratories COM 002824100 65,000 0 0.00 2,555 -6.03 0.4266
2016-05-13 2016-03-31 13F Abbott Laboratories COM 002824100 65,000 5,000 8.33 2,719 0.89 0.3796
2016-02-12 2015-12-31 13F Abbott Laboratories COM 002824100 60,000 5,000 9.09 2,695 21.84 0.3761
2015-11-13 2015-09-30 13F Abbott Laboratories COM 002824100 55,000 55,000 0.00 2,212 0.2245
2015-08-14 2015-06-30 13F Abbott Laboratories COM 002824100 0 -100,000 -100.00 0 -100.00
2015-05-15 2015-03-31 13F Abbott Laboratories COM 002824100 100,000 0 0.00 4,633 2.91 0.4792
2015-02-13 2014-12-31 13F Abbott Laboratories COM 002824100 100,000 0 0.00 4,502 8.25 0.4970
2014-11-14 2014-09-30 13F Abbott Laboratories COM 002824100 100,000 0 0.00 4,159 1.69 0.5712
2014-08-14 2014-06-30 13F Abbott Laboratories COM 002824100 100,000 0 0.00 4,090 6.21 0.4814
2014-05-15 2014-03-31 13F Abbott Laboratories COM 002824100 100,000 -50,000 -33.33 3,851 -33.03 0.4103
2014-02-14 2013-12-31 13F Abbott Laboratories COM 002824100 150,000 0 0.00 5,750 15.49 0.6118
2013-11-14 2013-09-30 13F Abbott Laboratories COM 002824100 150,000 150,000 4,979 0.5426
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.